Pomalidomide and low-dose dexamethasone improves health-related quality of life and prolongs time to worsening in relapsed/refractory patients with multiple myeloma enrolled in the MM-003 randomized phase III trial

Weisel, Katja; Dimopoulos, Meletios; Song, Kevin W.; Moreau, Philippe; Palumbo, Antonio; Belch, Andrew; Schey, Stephen; Sonneveld, Pieter; Sternas, Lars; Yu, Xin; Amatya, Ramesh; Gibson, Craig J.; Zaki, Mohamed; Jacques, Christian; San Miguel, Jesus

dc.contributor.author	Weisel, Katja
dc.date.accessioned	2016-03-16T16:33:30Z
dc.date.available	2016-03-16T16:33:30Z
dc.date.issued	2015
dc.identifier.issn	2152-2650
dc.identifier.uri	http://hdl.handle.net/10900/68859
dc.language.iso	en	de_DE
dc.publisher	Cig Media Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.clml.2015.05.007	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Pomalidomide and low-dose dexamethasone improves health-related quality of life and prolongs time to worsening in relapsed/refractory patients with multiple myeloma enrolled in the MM-003 randomized phase III trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20151209042647_00694
utue.publikation.seiten	519-530	de_DE
utue.personen.roh	Weisel, Katja
utue.personen.roh	Dimopoulos, Meletios
utue.personen.roh	Song, Kevin W.
utue.personen.roh	Moreau, Philippe
utue.personen.roh	Palumbo, Antonio
utue.personen.roh	Belch, Andrew
utue.personen.roh	Schey, Stephen
utue.personen.roh	Sonneveld, Pieter
utue.personen.roh	Sternas, Lars
utue.personen.roh	Yu, Xin
utue.personen.roh	Amatya, Ramesh
utue.personen.roh	Gibson, Craig J.
utue.personen.roh	Zaki, Mohamed
utue.personen.roh	Jacques, Christian
utue.personen.roh	San Miguel, Jesus
dcterms.isPartOf.ZSTitelID	Clinical Lymphoma Myeloma & Leukemia	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE